Figure 2.

Survival curves of patients with clinically detectable peritoneal dissemination, treated by neoadjuvant intraperitoneal or systemic chemotherapy. All patients had P2 or P3 peritoneal dissemination. Fifty‐seven patients were treated with neoadjuvant intraperitoneal–systemic chemotherapy, using intraperitoneal administration of 30 mg/m² docetaxel and 100 mg/m² carboplatin with 1000 mL saline from a peritoneal port system, and intravenous infusion of 100 mg/m² methotrexate and 600 mg/m² 5‐fluorouracil via a peripheral vein. Surgical exploration was done in 51 patients, and 28 patients received peritonectomy. Gastrectomy alone was done in 23 patients. Survival of patients who underwent peritonectomy showed the best prognosis. 2 y.s.r., 2‐year survival rate; MST, median survival time.